Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Renal Ventures Management

Request full access

Provider of dialysis services for patients

Lakewood, United StatesFounded 1997Health

About Renal Ventures Management

Established in 1997, Renal Ventures Management carved a niche in the U.S. healthcare sector as a provider of dialysis services for patients with end-stage renal disease. The company's business model was centered on forming co-venture partnerships with local nephrologists, a strategy that allowed physicians to maintain autonomy over patient care while benefiting from centralized administrative support. This support structure included services such as billing, collections, purchasing, and operational systems, enabling partner physicians to compete more effectively in their local markets.

Renal Ventures operated by building and managing new dialysis centers, as well as selectively acquiring existing ones. The company's management services arm, RenalServ, was responsible for providing and managing highly trained staff for these clinics. A significant milestone occurred in 2011 when the company secured a $30 million capital investment from Goldman Sachs to fuel growth initiatives, including center acquisitions and the expansion of related services. By that time, the company, led by co-founder and VP of strategic services Ellen Davis and CEO Larry Chatfield, operated 25 dialysis centers across six states.

The company's trajectory culminated in its acquisition by DaVita, a leading kidney care provider, in a deal first announced in August 2015 and finalized on May 1, 2017. The initial acquisition price was reported at $415 million, which was later adjusted to approximately $358 million after excluding Renal Ventures' infusion business. At the time of the acquisition agreement, Renal Ventures operated 36 dialysis clinics. The transaction positioned Renal Ventures, then the seventh-largest dialysis provider in the U.S., within the portfolio of the second-largest provider, DaVita. Due to antitrust concerns from the Federal Trade Commission regarding reduced competition in specific local markets, DaVita was required to divest seven of the acquired clinics as a condition of the deal's approval.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
174
Open positions
None listed
Dealroom signal
59.3/100

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Aug 2015 $415M $415M DaVita —
LATE VC✓Equity / VC Jan 2011 $30M $120M Goldman Sachs —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Renal Ventures Management website traffic

Latest recorded traffic for Renal Ventures Management is 130 monthly website visits. Renal Ventures Management's team declined 0.6% over the past year.

Latest monthly visits130 1-year team growth-0.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Renal Ventures Management in the Lakewood ecosystem

Live from Dealroom

The Renal Ventures Management office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

Other known investors1 additional known investor

  • DaVita
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Renal Ventures Management on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Renal Ventures Management’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.